Recombinant epidermal growth factor (Shanghai Dajiang Group)

重组人表皮生长因子（上海大江集团）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant epidermal growth factor (Shanghai Dajiang Group)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSkin Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShanghai Dajiang (Group) Co Ltd Biopharmaceutical Company
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Dajiang (Group) Co Ltd Biopharmaceutical Company
Active IndicationsN/A
Inactive IndicationsSkin Ulcer

Other Information

ATC CodeN/A
Related LinksN/A